EP2857394A1 — Antiviral compounds
Assigned to Gilead Pharmasset LLC · Expires 2015-04-08 · 11y expired
What this patent protects
The invention is related to anti-viral compounds of formula (Ic): E-V-Z-P-M-A-A-M-P-Z-V-E (Ic) or a pharmaceutically acceptable salt thereof, wherein: each E is methoxycarbonylamino; each V is V 0 ; each Z is -C(=O)-; each P is each M is independently imidazolyl or be…
USPTO Abstract
The invention is related to anti-viral compounds of formula (Ic): E-V-Z-P-M-A-A-M-P-Z-V-E (Ic) or a pharmaceutically acceptable salt thereof, wherein: each E is methoxycarbonylamino; each V is V 0 ; each Z is -C(=O)-; each P is each M is independently imidazolyl or benzimidazolyl; compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.